FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE
FOXO Technologies Inc. (NYSE American: FOXO) announced the expansion of services at its Big South Fork Medical Center in Oneida, Tennessee, to include wound care services starting June 2, 2025. The hospital, which currently serves over 600 emergency room patients and 300 outpatients monthly, will offer both inpatient and outpatient wound care services.
The expansion addresses a growing need for wound care services, particularly for diabetic patients. According to the CDC, as of 2021, over 38 million diabetes patients existed in the U.S., with up to 15% experiencing diabetic foot ulcers. The hospital is currently reconfiguring space and making key clinical hires to support this initiative.
FOXO Technologies Inc. (NYSE American: FOXO) ha annunciato l'ampliamento dei servizi presso il suo Big South Fork Medical Center a Oneida, Tennessee, che includerà servizi di cura delle ferite a partire dal 2 giugno 2025. L'ospedale, che attualmente assiste oltre 600 pazienti al pronto soccorso e 300 pazienti ambulatoriali ogni mese, offrirà servizi di cura delle ferite sia per pazienti ricoverati che ambulatoriali.
Questa espansione risponde a una crescente necessità di servizi per la cura delle ferite, in particolare per i pazienti diabetici. Secondo i dati del CDC, nel 2021 negli Stati Uniti c'erano oltre 38 milioni di pazienti diabetici, con fino al 15% che soffre di ulcere diabetiche ai piedi. L'ospedale sta attualmente riorganizzando gli spazi e assumendo personale clinico chiave per supportare questa iniziativa.
FOXO Technologies Inc. (NYSE American: FOXO) anunció la ampliación de los servicios en su Big South Fork Medical Center en Oneida, Tennessee, para incluir servicios de cuidado de heridas a partir del 2 de junio de 2025. El hospital, que actualmente atiende a más de 600 pacientes en urgencias y 300 pacientes ambulatorios al mes, ofrecerá servicios de cuidado de heridas tanto para pacientes hospitalizados como ambulatorios.
Esta expansión responde a una creciente necesidad de servicios de cuidado de heridas, especialmente para pacientes diabéticos. Según el CDC, en 2021 había más de 38 millones de pacientes con diabetes en EE. UU., con hasta un 15% que experimenta úlceras en los pies diabéticos. El hospital está actualmente reconfigurando espacios y realizando contrataciones clínicas clave para apoyar esta iniciativa.
FOXO Technologies Inc. (NYSE American: FOXO)는 테네시 주 오네이다에 위치한 Big South Fork Medical Center에서 2025년 6월 2일부터 상처 치료 서비스를 확대 제공한다고 발표했습니다. 이 병원은 현재 매달 600명 이상의 응급실 환자와 300명의 외래 환자를 치료하고 있으며, 입원 환자와 외래 환자 모두를 위한 상처 치료 서비스를 제공할 예정입니다.
이번 서비스 확장은 특히 당뇨병 환자들의 상처 치료 수요 증가에 대응하기 위한 것입니다. CDC에 따르면 2021년 기준 미국 내 당뇨병 환자는 3,800만 명 이상이며, 이 중 최대 15%가 당뇨병성 족부 궤양을 경험하고 있습니다. 병원은 현재 이 계획을 지원하기 위해 공간 재배치와 주요 임상 인력 채용을 진행 중입니다.
FOXO Technologies Inc. (NYSE American: FOXO) a annoncé l'extension des services de son Big South Fork Medical Center à Oneida, Tennessee, pour inclure des services de soins des plaies à partir du 2 juin 2025. L'hôpital, qui traite actuellement plus de 600 patients aux urgences et 300 patients externes par mois, offrira des soins des plaies pour les patients hospitalisés et ambulatoires.
Cette expansion répond à un besoin croissant de soins des plaies, en particulier pour les patients diabétiques. Selon le CDC, en 2021, il y avait plus de 38 millions de patients diabétiques aux États-Unis, avec jusqu'à 15% souffrant d'ulcères du pied diabétique. L'hôpital est en train de réaménager ses espaces et de recruter du personnel clinique clé pour soutenir cette initiative.
FOXO Technologies Inc. (NYSE American: FOXO) gab die Erweiterung der Dienstleistungen im Big South Fork Medical Center in Oneida, Tennessee, bekannt, die ab dem 2. Juni 2025 Wundversorgung umfassen wird. Das Krankenhaus, das derzeit monatlich über 600 Notfallpatienten und 300 ambulante Patienten versorgt, wird sowohl stationäre als auch ambulante Wundversorgungsdienste anbieten.
Die Erweiterung reagiert auf einen wachsenden Bedarf an Wundversorgung, insbesondere bei Diabetespatienten. Laut CDC gab es 2021 in den USA über 38 Millionen Diabetespatienten, von denen bis zu 15% an diabetischen Fußgeschwüren leiden. Das Krankenhaus richtet derzeit Räumlichkeiten um und stellt wichtige klinische Fachkräfte ein, um diese Initiative zu unterstützen.
- Expansion of service offerings to include wound care services, addressing a significant market need
- Large addressable market with over 38 million diabetes patients in the U.S.
- Expected increase in revenue through new service line
- Building upon existing patient base of 900+ monthly patients
- Requires investment in facility reconfiguration and new staff hiring
- Success depends on successful implementation and patient adoption
Insights
FOXO's hospital adding wound care services targets growing diabetic patient needs, potentially boosting revenue in underserved rural market.
FOXO Technologies is making a strategic service expansion at its Big South Fork Medical Center in rural Tennessee with the addition of wound care services starting June 2, 2025. This development addresses a significant market need, particularly for diabetic patients who frequently require specialized wound treatment. According to CDC data cited in the release, the U.S. has over 38 million diabetes patients, with up to
The timing of this expansion appears well-calculated. The hospital already serves a substantial patient base with 600+ monthly ER visits and approximately 300 monthly outpatient visits. By adding wound care capabilities that can serve both inpatient and outpatient populations, the facility is leveraging its existing infrastructure while expanding its billable service offerings. This approach typically allows for improved operational efficiency through higher utilization of fixed costs.
Rural healthcare facilities face unique challenges but also enjoy reduced competition. As a critical access hospital, Big South Fork likely benefits from enhanced Medicare reimbursement rates (typically cost-plus-
The reference to "further expand our footprint in East Tennessee" suggests this may be the first step in a broader regional growth strategy, potentially indicating future acquisitions or additional service line expansions in the area. Rural healthcare consolidation continues to be a significant trend as smaller facilities seek economies of scale.
WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, is expanding its services by offering wound care services to patients on an inpatient and outpatient basis. The hospital intends to commence such services on June 2, 2025, and expects to complete the reconfiguration of certain space at the hospital and addition of key clinical hires to facilitate this expected start date.
The hospital has experienced a growing need for wound care services particularly for diabetic patients who have wounds often characterized by excessive inflammation and reduced angiogenesis and have a higher risk for postoperative wound healing complications. According to the U.S. Centers for Disease Control and Prevention, in 2021 there were over 38 million diabetes patients in the U.S. with up to
Hal Leftwich, Chief Executive Officer of Big South Fork Medical Center stated, “We are excited about expanding our service offerings to patients in our communities. Wound care is a vital new service that we will offer to patients as we broaden our overall service offerings. This new service will build on our rural hospital that cares for over 600 patients in the emergency room and approximately 300 patients on an outpatient basis monthly.” Seamus Lagan, Chief Executive Officer of parent company, FOXO Technologies Inc., further added, “we are pleased that our rural hospital is expanding its services that will, in turn, increase revenues and are working closely with hospital management to consider options available to us to further expand our footprint in East Tennessee.”
About FOXO Technologies Inc. (“FOXO”)
FOXO owns and operates three subsidiaries.
Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical), a critical access designated (CAH) hospital in East Tennessee.
Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.
FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.
For more information about FOXO, visit www.foxotechnologies.com.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151
FAQ
When will FOXO Technologies' Big South Fork Medical Center start offering wound care services?
How many patients does FOXO's Big South Fork Medical Center currently serve?
What is the market size for wound care services according to FOXO's announcement?
Where is FOXO Technologies' Big South Fork Medical Center located?
What type of wound care services will FOXO's hospital provide?
